[go: up one dir, main page]

EA201992558A1 - Варианты белка bmp7 человека - Google Patents

Варианты белка bmp7 человека

Info

Publication number
EA201992558A1
EA201992558A1 EA201992558A EA201992558A EA201992558A1 EA 201992558 A1 EA201992558 A1 EA 201992558A1 EA 201992558 A EA201992558 A EA 201992558A EA 201992558 A EA201992558 A EA 201992558A EA 201992558 A1 EA201992558 A1 EA 201992558A1
Authority
EA
Eurasian Patent Office
Prior art keywords
bmp7
relates
present
human protein
options
Prior art date
Application number
EA201992558A
Other languages
English (en)
Inventor
Джеймс Дэвид Пэнкук
Скотт Уильям Роулинсон
Луи Франк Станкато
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA201992558A1 publication Critical patent/EA201992558A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1875Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2857Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, orphan receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Настоящее изобретение относится к новым вариантам белка BMP7 человека. Настоящее изобретение относится к векторам и клеткам-хозяевам для воспроизводства последовательностей нуклеиновой кислоты, кодирующих указанные белки, и их получения. Настоящее изобретение также относится к способам лечения злокачественного новообразования, повреждения и дегенерации хрящевой ткани, боли, ассоциированной с остеоартритом, или сращения кости.
EA201992558A 2017-04-27 2018-04-20 Варианты белка bmp7 человека EA201992558A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762490910P 2017-04-27 2017-04-27
PCT/US2018/028496 WO2018200322A1 (en) 2017-04-27 2018-04-20 Variants of human bmp7 protein

Publications (1)

Publication Number Publication Date
EA201992558A1 true EA201992558A1 (ru) 2020-03-04

Family

ID=62196685

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201992558A EA201992558A1 (ru) 2017-04-27 2018-04-20 Варианты белка bmp7 человека

Country Status (17)

Country Link
US (1) US11466066B2 (ru)
EP (1) EP3615561B1 (ru)
JP (1) JP7308151B2 (ru)
KR (1) KR20200012870A (ru)
CN (1) CN110997708A (ru)
AU (1) AU2018258100B2 (ru)
BR (1) BR112019022566A2 (ru)
CA (1) CA3061606A1 (ru)
CL (1) CL2019003074A1 (ru)
CO (1) CO2019013150A2 (ru)
CR (1) CR20190539A (ru)
EA (1) EA201992558A1 (ru)
MX (1) MX2019012871A (ru)
PE (1) PE20200385A1 (ru)
PH (1) PH12019502442A1 (ru)
SG (1) SG11201910009UA (ru)
WO (1) WO2018200322A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12358963B2 (en) 2019-12-24 2025-07-15 Juvena Therapeutics, Inc. Regenerative polypeptides and uses thereof
JP2024525213A (ja) 2021-06-21 2024-07-10 ジュベナ セラピューティクス,インク. 再生ポリペプチドおよびその使用
KR20230003879A (ko) 2021-06-30 2023-01-06 현대자동차주식회사 하이브리드 차량의 림프홈 후진 주행 제어 시스템 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008500816A (ja) 2004-03-31 2008-01-17 ゼンコー・インコーポレイテッド 改善された性質を有するbmp−7変異体
JP5452230B2 (ja) 2006-12-21 2014-03-26 ストライカー コーポレイション 生物学的因子の結晶、高分子ゲルおよび粒子懸濁液を含む持続放出処方物
WO2008151258A2 (en) * 2007-06-04 2008-12-11 Neose Technologies, Inc. O-linked glycosylation using n-acetylglucosaminyl transferases
US7846428B2 (en) 2007-10-05 2010-12-07 Merial Limited Articular cartilage gene therapy with recombinant vector encoding BMP-7
AU2008345689B2 (en) * 2007-12-21 2013-04-18 Stryker Corporation BMP mutants with decreased susceptibility to Noggin

Also Published As

Publication number Publication date
CA3061606A1 (en) 2018-11-01
AU2018258100A1 (en) 2019-11-14
CN110997708A (zh) 2020-04-10
EP3615561A1 (en) 2020-03-04
US20210115100A1 (en) 2021-04-22
WO2018200322A1 (en) 2018-11-01
JP2020517706A (ja) 2020-06-18
SG11201910009UA (en) 2019-11-28
BR112019022566A2 (pt) 2020-05-19
EP3615561C0 (en) 2024-01-10
CR20190539A (es) 2020-03-26
MX2019012871A (es) 2021-01-08
EP3615561B1 (en) 2024-01-10
AU2018258100B2 (en) 2022-04-14
PH12019502442A1 (en) 2020-10-05
CO2019013150A2 (es) 2020-02-28
CL2019003074A1 (es) 2020-05-08
KR20200012870A (ko) 2020-02-05
JP7308151B2 (ja) 2023-07-13
US11466066B2 (en) 2022-10-11
PE20200385A1 (es) 2020-02-24

Similar Documents

Publication Publication Date Title
EA201892561A1 (ru) Гибридные белки gdf15 и их применение
PH12019500122A1 (en) Bispecific antibody-like binding proteins specifically binding to cd3 and cd123
EA201892616A1 (ru) Антитела к pd1 и lag3 для лечения злокачественного новообразования
EA201792573A1 (ru) Триспецифические связанные белки и способы их применения
EA202091995A1 (ru) Композиции и способы лечения не связанного с возрастом нарушения слуха у субъекта-человека
JOP20220079A1 (ar) بروتين ربط متعددة الخصوصية لمعالجة السرطان
EA202090817A1 (ru) Триспецифические белки и способы их применения
EA201992063A1 (ru) СВЯЗЫВАЮЩИЕ ErbB-2 И ErbB-3 БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА ДЛЯ ПРИМЕНЕНИЯ ДЛЯ ЛЕЧЕНИЯ КЛЕТОК, КОТОРЫЕ СОДЕРЖАТ СЛИТЫЙ ГЕН NRG-1
EA201890640A1 (ru) Рекомбинантные векторы, содержащие пептид 2а
MX2021015182A (es) Casetes optimizados de expresion del gen humano del factor viii de coagulacion y su uso.
MX395421B (es) Moleculas de acido nucleico artificiales.
EA201690529A1 (ru) Способы модификации клетки-хозяина
MY199683A (en) Anti-pd-1 antibodies
MX385207B (es) Aglutinantes de tnf mejorados.
MX2024014468A (es) Anticuerpos anti-cd63, conjugados y usos de estos
PH12022550460A1 (en) Anti-cd96 antibodies and methods of use thereof
PH12020550099A1 (en) Fusion protein comprising an fgf-18 moiety
EA201992558A1 (ru) Варианты белка bmp7 человека
PH12020550483A1 (en) Anti-apoc3 antibodies and methods of use thereof
EA201792274A1 (ru) Слитые молекулы вариант iii рецептора эпидермального фактора роста-мезотелин и способы их применения
PH12019502449A1 (en) Anti-jagged1 antigen binding proteins
MX2015012281A (es) Proteinas de union a tnf mejoradas.
WO2016160976A3 (en) Monovalent tnf binding proteins
EA202092769A1 (ru) Антитела против cd63, их конъюгаты и применения
EA201991181A1 (ru) Psma-нацеленные триспецифические белки и способы их применения